- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 220
Audeo listens in to $60m IPO
Alchemia acquired Audeo in 2006, when it was known as Meditech Research, paying $16.9m in shares plus a $2m loan.
Jul 10, 2012Fender to pluck up to $160m in IPO
Fender has been corporate-backed by Japan's Yamano Music and Kanda Shokai Corporation since the 1980s.
Jul 10, 2012GlobeImmune looks to $69m IPO
The healthcare company backed by Celgene and Eli Lilly's corporate venturing unit files to list on Nasdaq.
Jul 5, 2012Sinosun flotation rises
Intel Capital-backed Sinosun rose nearly 10% in its first day of trading on Thursday.
Jul 5, 2012Tesaro completes $81m flotation
The company priced six million common shares at $13.50 each, which was the middle of its $12 to $15 per share range and for an initial market capitalisation of $360m.
Jun 29, 2012OncoMed preps flotation
Investment banks Jefferies and Leerink Swann are co-lead underwriters of OncoMed's initial public offering (IPO).
May 27, 2012Kythera preps flotation
Investment banks JPMorgan and Goldman Sachs are co-lead underwriters of Kythera's initial public offering.
May 27, 2012Rib-x postpones IPO after slashing price
The antibiotics developer backed by SR One and MedImmune Ventures postponed its initial public offering a day after it halved the planned price of its float earlier this month.
May 23, 2012Microsoft's $1.15bn Facebook stake
The exact size of Microsoft's stake is outlined in the social network's latest regulatory filing.
May 4, 2012About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


